Yaoshibang, a Chinese B2B pharmaceutical trading platform, has raised a RMB110 million ($16 million) Series B round co-led by Shenzhen-based Green Pine Capital Partners and Fosun Group.
Existing investors Co-Power Capital and Ivy Capital also participated in the round. Operated by Guangzhou Speedroad Medical Information, Yaoshibang was launched in 2015 by a former executive at Chinese...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.
Northleaf Capital Partners, a Canada-based asset manager that invests in private equity, private credit, and infrastructure, has opened a Tokyo office to spearhead fundraising activity in Asia and is considering the addition of a Korea presence.